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Sympathetic stimulation has become a central tenet
in our understanding of how cardiac contractility is
dynamically altered to accommodate the changing
demands of the organism. The mechanisms by which
acute and chronic sympathetic stimulation of the
heart modulates cardiac output remain incompletely
understood, however. Beyond the increase in heart
rate driven by sympathetic stimulation of the sino-atrial
node, the 
 
 
 
-adrenergic receptor (
 
 
 
-AR)–mediated cas-
cade increases contractile force development (in-
otropy) and accelerates relaxation (lusitropy). Numer-
ous proteins have been discovered to be involved
in the 
 
 
 
-AR–stimulated response, including calcium
handling proteins, myoﬁlament proteins, G-proteins,
and regulators of myocardial metabolism (Bers, 2002).
The newest player on the ﬁeld is titin (Fig. 1), the
giant myoﬁlament protein that serves as an en-
tropic spring that imparts both the passive and the
restoring forces during diastole and systole, respec-
tively. Additional roles for titin have been proposed,
including regulation of sarcomere length dependence
of myoﬁlament calcium sensitivity, a molecular tem-
plate for thick ﬁlament assembly and sarcomere in-
tegrity, and centering of the A-band (Tskhovre-
bova and Trinick, 2003; Granzier and Labeit, 2004).
Granzier and colleagues recently have demonstrated
that titin is a target of PKA phosphorylation down-
stream of 
 
 
 
-AR activation, resulting in a change in
the titin-based passive force that increases myoﬁla-
ment compliance during sarcomere elongation (Ya-
masaki et al., 2002). In this issue, Granzier and col-
leagues have reﬁned our understanding further, dem-
onstrating that the effect of titin phosphorylation on
the passive as well as the restoring force is isoform
speciﬁc (Fukuda et al., 2005). This article adds to the
expanding literature that demonstrates the complex
role(s) of this giant protein as an important determi-
nant of not only sarcomere structure, but also as a
key regulator of dynamic changes in cardiac function
over both short (beat to beat) and long (day to day)
time frames.
 
Differential and Developmental Expression of Titin Isoforms
 
Full-length titin spans half the sarcomere with function-
ally distinct motifs in the Z-line, I-band, A-band, and
M-line of the sarcomere (Tskhovrebova and Trinick,
2003; Granzier and Labeit, 2004). It is the I-band
portion of titin that serves as a molecular spring that,
when stretched, imparts passive and restoring forces to
the cardiac myocyte, and thus inﬂuences the contractile
state of the heart. The elasticity of cardiac titin is de-
rived from three mechanically distinct, serially linked
spring elements: (1) tandem immunoglobulin (Ig)
repeats, (2) PEVK region (rich in proline, glutamate,
valine, and lysine residues), and (3) unique N2B region
(Helmes et al., 1999). Differential splicing of a single
titin gene allows for length variations in the Ig repeats
and PEVK segments, thus creating titins with different
extensibilities (Freiburg et al., 2000). Hearts from large
adult mammals (including humans) express predomi-
nantly two titin isoforms: N2B titin with a shorter exten-
sible region and higher passive stiffness and N2BA titin
with a longer extensible region and hence greater
compliance (Cazorla et al., 2000). In contrast, hearts
from small mammals express primarily the N2B isoform
and predictably have a higher passive stiffness.
Titin isoforms also are developmentally regulated as
fetal hearts express even more compliant titins, due
to the insertion of additional tandem Ig repeats and
PEVK sequences (fetal titins or N2BA1/N2BA2), which
eventually are replaced by the adult isoforms during
postnatal development (Lahmers et al., 2004; Opitz et
al., 2004). In diseased hearts, a shift in coexpression of
titin isoforms have been reported with a higher N2BA/
N2B ratio in human dilated cardiomyopathy and a
lower N2BA/N2B ratio in a pacing-induced canine
heart failure model (Neagoe et al., 2002; Wu et al.,
2002; Makarenko et al., 2004; Nagueh et al., 2004).
Importantly, the physiological, developmental, and patho-
logical shifts in titin isoforms that are observed in these
studies appear to predict changes in myocardial stiff-
ness and ventricular function. These results suggest
that titin isoform expression is one mechanism for
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modulating passive sarcomere mechanical properties
on a long time frame.
 
Acute Regulation of Titin Mechanics
 
In addition to PKA phosphorylation of titin, Granzier
and colleagues have reported a separate mechanism
for rapid adjustment of the molecular spring constant
of titin that also is isoform speciﬁc. In single molecules,
calcium lowers the bending rigidity of the PEVK seg-
ments that contain E-rich motifs (Labeit et al., 2003),
which is present in N2BA but not in N2B titin. Accord-
ingly, skinned muscle ﬁbers with predominantly N2BA
showed a calcium-dependent increase in titin passive
force, which was absent in ﬁbers expressing primarily
N2B, and the calcium-sensitive stiffness of the more
compliant N2BA titin was postulated to stabilize the sar-
comeres during contraction (Fujita et al., 2004). Inter-
estingly, previous work by the same group and others
(Kulke et al., 2001; Yamasaki et al., 2001) revealed that
the PEVK segment of N2B titin interacts with actin,
in vitro, and that this interaction is inhibited in the
presence of calcium by the calcium-binding protein
S100A1(Yamasaki et al., 2001). Whether titin-based ten-
sion is dynamically modulated during a single cardiac
cycle by calcium, particularly in vivo, remains to be
determined.
Hearts expressing predominantly N2B titin (such as
small rodents) are stiffer and have a higher intrinsic
heart rate, with reduced diastolic ﬁlling times. Yama-
saki et al. (2002) proposed that a reduction in ti-
tin passive tension via PKA phosphorylation would al-
low for a more rapid and complete ventricular ﬁlling,
thereby increasing end-diastolic volume and cardiac
output. This interpretation, however, does not take into
account a possible effect of calcium/S100A1 on titin
passive tension. In the article by Fukuda et al. (2005),
the PKA-induced changes are diminished in intact mus-
cle ﬁbers from rat ventricle (Fig. 7, where S100A1 is
present) when compared with skinned ﬁbers (Fig. 2,
where calcium is kept constant). Perhaps this is due to
an offset of the PKA effect by an increase in passive ten-
sion via PEVK–actin interactions, as the inhibitory ef-
fect of S100A1 diminishes with the fall in calcium dur-
ing diastole.
Fukuda et al. (2005) also demonstrate that the reduc-
tion in titin tension by PKA phosphorylation lowers re-
storing force at short sarcomere lengths. It is interest-
ing to speculate about the effect of this on cardiac out-
put. Fukuda and colleagues suggest that lowering the
restoring force might have detrimental effects on myo-
cardial efﬁciency due to a reduction of the length-
dependent deactivation effect of titin at the systolic–
diastolic transition. One could also argue that a reduc-
tion in restoring force will improve cardiac output. The
drop in restoring force would predictably allow for
lower end-systolic volumes at any given afterload by de-
creasing the resistance to myoﬁlament shortening, al-
lowing the ventricle to reach lower chamber volumes,
and thus increasing stroke volume. In addition, the de-
crease in titin-based tension due to PKA phosphoryla-
tion is further enhanced during systole by inhibition of
PEVK–actin interaction via S100A1 as calcium levels
rise. Thus, the PKA and calcium effects on titin-based
restoring force work together to enhance ventricular
emptying and increase cardiac output. The overall im-
Figure 1. Excitation–contraction (EC) coupling and the response
to  -adrenergic receptor ( -AR) stimulation. (A) EC coupling
involves depolarization of the transverse tubule that activates
voltage-gated L-type calcium channels (LTCC). Inﬂux of calcium
through LTCC triggers a greater calcium release from the SR into
the cytoplasm via ryanodine receptor (RyR) channels, which
activates contraction. Relaxation occurs when cytoplasmic calcium
is resequestered by the SR calcium-ATPase (SERCA2a), which is
regulated by phospholamban (PLB). The excess calcium that
entered the cell via the LTCCs is eventually extruded by the
sarcolemmal sodium/calcium exchanger (NCX). (B)  -AR stimu-
lation involves binding of epinephrine and norepinephrine to the
receptor, G protein–mediated activation of adenylate cyclase (AC),
synthesis of cyclic AMP (cAMP), and activation of PKA. PKA-
dependent phosphorylation of calcium handling and myoﬁlament
proteins are depicted in red. Asterisk denotes potential modula-
tion of titin spring constant by calcium and/or calcium/S100A1.
The overall effect of PKA phosphorylation is an augmentation in
myocardial inotropy and lusitropy. 
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pact of a diminished titin-based restoring force on the
efﬁciency of the systolic–diastolic transition may be
minimized as elastic recoil is partially restored with the
reversal of S100A1 inhibition on PEVK–actin interac-
tion as calcium levels fall during diastole. In hearts ex-
pressing both N2B and N2BA isoforms, the picture be-
comes even more complex. In addition to the isoform-
speciﬁc effects of PKA, the N2BA and N2B effects
of calcium and calcium/S100A1 (which have oppos-
ing actions on titin stiffness) also must be taken into
consideration.
While mostly speculative at this point, the ability of
PKA and calcium to dynamically vary titin stiffness
within a single cardiac cycle is a new and intriguing
concept. Further studies are warranted to fully eluci-
date the extent to which these events independently or
in concert regulate cardiac function.
 
Isoform Shifts in Diseased Hearts: Adaptive or Maladaptive?
 
One cannot help but marvel at how the cardiac myo-
cyte has evolved this ability to dynamically regulate
length-dependent changes in cardiac contractility, both
on a short timescale through phosphorylation–dephos-
phorylation and calcium regulation of titin stiffness,
and on a longer time scale through changes in isoform
expression. This adaptability arguably maximizes myo-
cardial efﬁciency, by changing the spring constant and
myoﬁlament calcium-sensitizing properties of titin to
match the workload. It is interesting that the short-term
changes in titin mechanics appear to be most tightly
coupled to the inotropic state of the heart. In contrast,
the long-term changes in isoform expression appear to
relate most clearly to ventricular chamber size and/or
resting heart rate.
Based upon Granzier and colleagues’ prior work,
though, there appears to be a maladaptive loss of the
ability of the myoﬁlaments to dynamically regulate pas-
sive tension in the setting of chronic heart failure.
Nagueh et al. (2004) reported recently that in the ven-
tricle of patients with end-stage human heart failure
there is an increase in the N2BA/N2B ratio. A careful
evaluation of the mechanical properties of the myocar-
dium revealed that the shift toward increased expres-
sion of the longer isoform led to an increase in the
titin-based compliance of the cardiac muscle. More-
over, the investigators were able to show that the in vivo
parameters of diastolic function at rest correlated with
the N2BA/N2B ratio. Thus at rest, they proposed that a
shift toward the longer N2BA isoform might be consid-
ered an adaptive strategy to improve cardiac diastolic
function in the failing heart (LeWinter, 2004). How-
ever like many adaptations to the pathological condi-
tion of reduced cardiac output, this appears to be at
least “short-sighted,” if not maladaptive. The longer
N2BA isoform will maximize compliance of the ventri-
cle, and allow the heart to begin systole at longer sarco-
mere lengths, and higher end-diastolic volumes. With
an impaired Frank-Starling mechanism for length-
dependent activation, the expected gain in contractility
normally associated with sarcomere elongation will be
absent. Given the new ﬁnding that the N2BA isoform
does not change stiffness in response to PKA-depen-
dent phosphorylation provides another mechanism for
the impaired responsiveness of the failing heart to
 
 
 
-AR stimulation. Moreover, the higher end-diastolic
volumes that will be achieved with the less stiff N2BA
isoform will result in an increase in wall stress at any
given pressure, and therefore may add in a feed-forward
manner to the well-characterized process of ventricular
remodeling. Further work is needed to understand the
obviously complex mechanisms regulating titin isoform
expression, and the extent to which these changes are
desirable or undesirable adaptations to conditions of
increased load.
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